This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Adlai Nortye Biopharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kaixuan Chen: Innovator in Biopharmaceuticals
Introduction: Kaixuan Chen is a notable inventor based in Hangzhou, China. He is currently associated with Adlai Nortye Biopharma Co., Ltd., where he contributes to advancements in biopharmaceutical research. His work focuses on developing innovative solutions for various medical conditions.
Latest Patent Applications: Kaixuan Chen has filed a patent application titled "WNT PATHWAY INHIBITOR COMPOUNDS." This application presents a compound of formula I or a pharmaceutically acceptable salt, isotope derivative, or stereoisomer thereof, which exhibits excellent Wnt pathway inhibitory activity. The disclosure also outlines a method for preparing the compound and its potential use in preventing and/or treating cancer, tumors, inflammatory diseases, autoimmune diseases, or immune-mediated diseases.
Conclusion: Kaixuan Chen's contributions to the field of biopharmaceuticals highlight his commitment to innovation and research. His work has the potential to impact the treatment of various diseases significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile